Altimmune, AstraZeneca and Alnylam Pharmaceuticals

Altimmune 
Altimmune (ALT) stock soared last Friday after speculation of a takeover by three large companies.  The speculation died today. Nevertheless, other news about this firm could be important, especially from  Altimmune itself. The firm announced that it will assess the potential of GLP . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.